Pre-clinical imaging (In-VIVO) market worth $797 million by 2019: report

by Lauren Dubinsky, Senior Reporter | February 02, 2015
A new MarketsandMarkets report predicts the global pre-clinical imaging market is "expected to reach" $797 million by 2019, at a CAGR of 6.0 percent from 2014 to 2019.

The report broke down the global pre-clinical imaging market into seven segments: optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems.

Key factors impacting the market included technological advancements in molecular imaging, rising adoption of multi-modality imaging systems in pre-clinical research studies, and the increased acceptance of pre-clinical imaging in drug discovery and development, the report found.

This greater demand was offset by declining NIH budgets for medical science research studies, and high implementation cost of sophisticated pre-clinical imaging systems, the report also advised.

As of 2014, North America holds the largest share of the global pre-clinical imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2 percent from 2014 to 2019.

You Must Be Logged In To Post A Comment